RecruitingPhase 3NCT06472245
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Sponsor: OSE Immunotherapeutics
Babylon, NY · Brewster, NY · Brooklyn, NY · +76 more sites